Open Access

Inflammatory microcrystals induce murine macrophage survival and DNA synthesis

  • John A Hamilton1Email author,
  • Geraldine McCarthy2 and
  • Genevieve Whitty1
Arthritis Research & Therapy20013:242

https://doi.org/10.1186/ar308

Received: 5 January 2001

Accepted: 6 March 2001

Published: 26 March 2001

Abstract

The interaction of particulates with resident macrophages is a consistent feature in certain forms of crystal-induced inflammation, for example, in synovial tissues, lung, and the peritoneum. The mitogenic activity of basic calcium phosphate (BCP) crystals and calcium pyrophosphate dihydrate (CPPD) crystals on synovial fibroblasts has been considered relevant to the synovial hyperplasia observed in crystal-induced arthritis. The aim of the study was to determine whether microcrystals such as these could enhance macrophage survival and induce DNA synthesis, thus indicating that they may contribute to the tissue hyperplasia.

Murine bone-marrow-derived macrophages were treated in vitro with microcrystals, the cell numbers were monitored over time, and DNA synthesis was measured as the incorporation of [methyl-3H]thymidine (TdR). We report here that BCP, monosodium urate, talc, and, to a lesser extent, CPPD crystals promote macrophage survival and DNA synthesis; the latter response is particularly striking in the presence of low concentrations of macrophage-colony stimulating factor (M-CSF, CSF-1). Enhanced macrophage survival or proliferation may contribute to the synovial hyperplasia noted in crystal-associated arthropathies, as well as to talc-induced inflammation and granuloma formation. The crystals studied join the list of particulates having these effects on macrophages, indicating the generality of this type of response.

Keywords

crystals DNA synthesis macrophages survival

Introduction

Intra-articular basic calcium phosphate (BCP) (hydroxyapatite, octacalcium phosphate, tricalcium phosphate) crystal-deposition disease is associated clinically with severe degenerative arthritis characterized by hyperplasia of the synovial lining and loss of intrasynovial collagenous structures [1]. The interaction of the crystals with inflammatory cells is believed to be a key factor in crystal-induced inflammation [2].

Deposition of calcium pyrophosphate dihydrate (CPPD) crystals has been associated with the acute inflammatory arthritis of 'pseudogout' [3]. Synovial thickening is a common clinical finding in the affected joints of patients with deposition of CPPD crystals. Histologically, synovial-cell hyperplasia and infiltration by mononuclear inflammatory cells are seen [3,4]; CPPD crystals are phagocytosed by cells of the synovial lining [4]. Gout, pseudogout, and acute articular and periarticular inflammation caused by BCP crystals can behave similarly, reflecting the fact that BCP and CPPD crystals share many of the fundamental mechanisms of cell activation utilized by urate crystals [5,6]. Acute gout, even though initiated by deposition of monosodium urate (MSU) crystals in the synovium, is often associated with systemic inflammatory manifestations [7].

Talc (magnesium silicate) crystals, present in aerosols of respirable talc and surgical gloves, can cause, respectively, inflammatory reactions in the lung or a granulomatous reaction with peritoneal adhesions [8,9]. Exposure to talc leads to the development of granulomas containing macrophages [10]. Injection of talc into rabbit knees induces synovitis [11].

Macrophage-colony-stimulating factor (M-CSF), also called colony stimulating factor-1 (CSF-1), is an important regulator of the development and function of macrophage lineages throughout the body [12]. There are in vivo data suggesting that both synovial and peritoneal macrophages are completely dependent upon CSF-1 for their development [13].

One cell type that is normally resident in the synovium, and interacts in vivo with the various crystals mentioned above, is the macrophage (mononuclear phagocyte) [4]. We have previously shown that a number of particulates, including oxidized low-density lipoprotein (oxLDL) [14], adjuvants [15], and β-amyloid and prion protein fibrillogenic peptides (manuscript in preparation), were able to induce macrophage survival; they could also induce a proliferative response, particularly in the presence of circulating concentrations of CSF-1. We report here that BCP, MSU, talc, and, to a lesser extent, CPPD all promote the survival of murine bone marrow-derived macrophages (BMMs) and the synthesis of DNA, the latter response being potentiated again by low (suboptimal) CSF-1 concentrations.

Materials and methods

Bone marrow-derived macrophages, cell numbers, and DNA synthesis

As before, BMMs were generated as adherent cells from their nonadherent progenitors in the bone marrow of CBA mice (obtained from Monash University Animal Services, Clayton) and grown to confluence in 24-well plates (Nunc, Roskilde, Denmark) in the presence of CSF-1 (≥ 10,000 U/ml) [14,15]; the cells were prepared for an experiment by being washed twice with phosphate-buffered saline solution and the experiment was commenced immediately. For counting of BMMs, the medium was removed and the cells were gently scraped; viable cells were counted in a hemocytometer with the use of trypan blue exclusion [14]. DNA synthesis was measured as the incorporation of [methyl-3H]thymidine (TdR) (2 μCi/ml) as before [14,15].

Crystals

BCP crystals were synthesized by a modification of published methods [6]. The crystals were crushed and sieved to yield aggregates 10–20 μm in diameter, which were sterilized and rendered pyrogen free by heating at 200°C for 90 min. Triclinic CPPD crystals (10–50 μm in diameter) were synthesized and characterized as described elsewhere [16]. MSU monohydrate crystals (2–30 μm in diameter) were prepared from twice-recrystallized uric acid (Sigma Co, St Louis, MO, USA) and sodium hydroxide as previously described [17] and heated to 180°C for 2 h to render them pyrogen-free. Talc was US Pharmacopcia grade, as used clinically for pleurodesis; it was a gift from A Allison, Palo Alto, CA, USA. All crystals were resuspended in RPMI before culture.

Reagents

The following reagents were obtained from commercial sources: [3H]TdR (80 Ci/mmol; Amersham Corp) and FBS (CSL, Parkville, Australia). Recombinant human CSF-1 (M-CSF) was a gift from Chiron Corp., Emeryville, CA, USA. All practical precautions for minimizing endotoxin contamination were taken [14,15].

Statistical analysis

Student's two-tailed t-test was used for the comparison of two mean values; P < 0.05 was considered statistically significant.

Results

Effect of crystals on macrophage survival

Upon removal of CSF-1, BMMs gradually die by apoptosis [18]. However, as seen in Table 1, BCP crystals and, to a lesser extent, CPPD crystals prevented cell loss. For BCP, there was still activity at 50 μg/ml, and the optimal concentration for enhanced survival was ≥ 100 μg/ml (data not shown). The concentrations of BCP and CPPD used were determined from previous studies of dose–response relationships and the mitogenic response in fibroblasts [17], and from the concentrations found in pathologic joint fluids [6].
Table 1

Effect of BCP and CPPD on macrophage survival

Addition

No. of cells (×10-4)

None

  2.0 ± 0.2

BCP

12.7 ± 1.1

CPPD

   4.7 ± 0.2a

BMMs (13.0 ± 0.6 × 104) from which CSF-1 had just been removed were cultured in RPMI/10% FBS, in the absence or presence of BCP (500 μg/ml) or CPPD (500 μg/ml). After one day, cells were washed twice to remove cystals and recultured in RPMI/10% FBS for a further two days. Then the number of viable cells was determined by hemocytometer counting and trypan blue exclusion. Data are mean values ± SEM from triplicate cultures and are from a representative experiment that was repeated once. aP < 0.05 in comparison with untreated group (Student's two-tailed t-test).

Effect of crystals on macrophage DNA synthesis

We next determined whether the crystals induced BMMs to synthesize DNA. BCP stimulated BMM DNA synthesis in a dose–dependent manner (Fig. 1a); higher concentrations than those shown were toxic. CPPD, at its optimal concentration (500 μg/ml), stimulated BMM DNA synthesis (Table 2), albeit weakly in comparison with the effect of BCP and corresponding to its weaker effect on BMM survival.
Figure 1

Effect of BCP and talc doses on DNA synthesis in BMMs. BMMs from which CSF-1 had just been removed were cultured in RPMI/10%FBS, in the absence or presence of increasing concentrations of (a) BCP and (b) talc. After one day, cells were washed twice to remove crystals and recultured in RPMI/10%FBS containing [3H]TdR for a further two days. Data are mean values ± SEM from triplicate cultures and are from a representative experiment that was repeated five times.

Table 2

Effect of BCP and CPPD on macrophage DNA synthesis

Addition

[3H]TdR incorporation (cpm × 10-4)

None

  1.3 ± 0.1

BCP

25.2 ± 0.6

CPPD

   3.1 ± 0.1a

BMMs from which CSF-1 had just been removed were cultured as described in Table 1. After one day, cells were washed twice to remove cystals and recultured in RPMI/10% FBS containing [3H]TdR (2 μCi) for a further two days. Data are mean values ± SEMfrom triplicate cultures and are from a representative experiment that was repeated eight times. aP < 0.05 in comparison with untreated group (Student's two-tailed t-test).

MSU crystals promoted BMM DNA synthesis at the optimal concentration of 500 μg/ml (Table 3); they were active at ≥ 100 μg/ml (data not shown). The dose–response curve for talc, another biologically relevant particle, is presented in Fig. 1b; concentrations higher than those shown were toxic. The promotion of DNA synthesis by MSU and talc indicates that they also prevented cell death.
Table 3

Effect of monosodium urate on macrophage DNA synthesis

Addition

[3H]TdR incorporation (cpm × 10-4)

None

  1.6 ± 0.1

MSU

13.5 ± 0.5

BCP

24.3 ± 0.3

BMMs from which CSF-1 had just been removed were cultured in RPMI/10%FBS, in the absence or presence of monosodium urate (MSU) (500 μg/ml) or BCP (500 μg/ml). After one day, cells were pulsed with [3H]TdR for a further two days. Data are mean values ± SEM from triplicate cultures and are from a representative experiment that was repeated twice.

Effect of crystals in the presence of CSF-1

We have reported previously that other particulates, such as oxLDL and adjuvants, stimulate BMM DNA synthesis and they do this in a synergistic manner with CSF-1 [14,15]. As can be seen in Fig. 2, the stimulation of BMM DNA synthesis by BCP was potentiated by concentrations of CSF-1 that by themselves were suboptimal for the induction of DNA synthesis. For example, in the experiment whose data are provided, the [3H]TdR incorporation value of 8.1 ± 1.0 × 104 cpm resulting from the action of BCP alone rose to 22.4 ± 3.1 × 104 cpm in the presence of 315 U/ml CSF-1, which by itself gave a value of 4.4 ± 0.1 × 104 cpm. BMMs treated with MSU and talc also behaved similarly in the presence of a suboptimal concentration of CSF-1 (data not shown).
Figure 2

Effect of BCP on DNA synthesis in BMMs in the presence of CSF-1. BMMs from which CSF-1 had just been removed were cultured in RPMI/10%FBS in the presence of increasing concentrations of CSF-1, in either the absence () or the presence () of BCP (100 μg/ml). After one day, cells were washed twice to remove BCP, recultured again in the increasing CSF-1 concentrations, and pulsed with [3H]TdR for a further two days. Data are mean values ± SEM from triplicate cultures and are from a representative experiment that was repeated seven times.

Discussion

We have shown that a range of biologically relevant crystals promote macrophage survival and DNA synthesis, the latter response being more dramatic in the presence of suboptimal concentrations of CSF-1. Such enhancement of macrophage survival by crystals, if it occurred in vivo, would lengthen the cells' tenure in a lesion (e.g. synovium), with the result that more cells would be present to produce inflammatory mediators, such as cytokines, proteinases, eicosanoids etc, perhaps potentiated by additional stimuli. This phenomenon could be another mechanism contributing to the synovial hyperplasia attributed to crystals in joints [4]; it also may form part of how macrophage cell numbers increase in talc-induced granulomas and inflammatory reactions [10]. The degree of inflammation provoked experimentally by crystals in vivo is quite variable [5]. The capacity of crystal-treated monocytes or macrophages to produce inflammatory cytokines in vitro is likewise variable. For example, Malawista and coworkers found that the capacity of BCP and CPPD crystals to directly induce interleukin-1β and tumor necrosis factor-α in monocytes in vitro is weaker and less consistent than that of urate crystals [19]. In other words, the triggering of crystal-induced inflammation is not an 'all-or-nothing' response related to the new appearance of free crystals [5], and additional stimuli may be important.

The BMMs used in the above studies are a CSF-1-dependent population. As mentioned, there is evidence in the mouse that synovial and peritoneal macrophages are two populations that show CSF-1 dependence for their development [13]. In this sense, BMMs may represent a suitable model for these cells. It is likely that macrophages in vivo will be exposed to the low circulating concentrations of CSF-1, presumably responsible for their survival and steady-state turnover [12]. Since there is evidence of elevated CSF-1 concentrations in synovial fluids from patients with rheumatoid arthritis [20], those concentrations may also be raised in crystal-containing joints as part of the inflammatory reaction. CSF-1 can have proinflammatory effects in murine models of arthritis [21,22], and CSF-1-deficient (op/op) mice do not develop collagen-induced arthritis [22]. Our findings suggest that when macrophages are exposed to, or 'loaded' with, the range of crystals analyzed above, they are 'primed', so that they are able to proliferate better in the presence of CSF-1 doses that are suboptimal, i.e. that normally provide a survival signal or a weak proliferative one in vivo. If this potentiation were occurring in vivo with crystal-'loaded' macrophages, then again it could be contributing to the previously mentioned hyperplasia in joints and granulomas.

As discussed earlier, a number of clinical observations have suggested that articular inflammatory cells are 'primed' by crystals to heightened responsiveness to local stimuli [5]. Other observations have suggested that crystal-induced synovial fibroblast proliferation is a mechanism for increasing the number of synovial cells, which would then be capable of eliciting inflammatory mediators [17]. By analogy, our studies suggest that enhanced local macrophage survival or proliferation in the synovium (or in granulomas) should also be considered, in the same way, as a possible contributing factor. In support of this concept, there is evidence in a lentivirus model of arthritis that macrophages proliferate in the synovium [23] and in various types of granuloma [24].

The range of active materials promoting macrophage survival and DNA synthesis in the studies mentioned above indicates that calcium is not a necessary component. In synovial fibroblasts, by contrast, MSU only very slightly stimulated DNA synthesis, if at all, compared with BCP and CPPD [17]. However, in agreement with the synovial fibroblast response [17], latex did not support DNA synthesis in BMMs [14].

Crystals therefore join the list of particulates — for example, oxLDL [14] and certain adjuvants (aluminum salts, emulsions of oil in water, silica) [15] — that we have found to be capable of promoting macrophage survival and DNA synthesis, with potentiation again being observed with suboptimal CSF-1 concentrations. In each instance, including that of the materials studied here, the responses of the macrophages have been proposed to account, in part at least, for the increased numbers of cells of macrophage lineage at various sites of chronic inflammation, for example, an atherosclerotic plaque, in response to particulates which are usually poorly degraded. Perhaps such a mechanism may be quite a general one, offering an explanation for the persistence (chronicity) of a number of inflammatory lesions leading to pathology. The molecular events responsible for the enhanced survival and proliferation await analysis.

Conclusion

BCP, MSU, talc, and, to a lesser extent, CPPD all promote murine macrophage survival and DNA synthesis, the latter response being potentiated by low (suboptimal) CSF-1 concentrations. Such enhanced macrophage survival or proliferation may contribute to the synovial hyperplasia noted in crystal-associated arthropathies, as well as to talc-induced inflammation. The crystals mentioned above can therefore be included in the list of particulates having these effects on macrophages, indicating the generality of this type of response.

Abbreviations

BCP: 

basic calcium phosphate

BMM: 

bone-marrow-derived macrophage

CSF-1: 

colony stimulating factor-1

CPPD: 

calcium pyrophosphate dihydrate

FBS: 

fetal bovine serum

M-CSF: 

macrophage-colony stimulating factor

MSU: 

monosodium urate

oxLDL: 

oxidized low-density lipoprotein

RPMI: 

Roswell Park Memorial Institute [medium]

TdR: 

thymidine.

Declarations

Acknowledgements

Supported by grants, including a Senior Principal Research Fellowship (JAH), from the National Health and Medical Research Council of Australia. We thank R Sallay for typing the manuscript.

Authors’ Affiliations

(1)
Arthritis and Inflammation Research Centre, Department of Medicine, The Royal Melbourne Hospital, University of Melbourne
(2)
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland

References

  1. Schumacher HR: Synovial inflammation, crystals, and osteoarthritis. J Rheumatol (Suppl). 1995, 43: 101-103.Google Scholar
  2. Prudhommeaux F, Schiltz C, Liote F, Hina A, Champy R, Bucki B, Ortiz-Bravo E, Meunier A, Rey C, Bardin T: Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum. 1996, 39: 1319-1326.PubMedView ArticleGoogle Scholar
  3. Ryan L, McCarty D: Calcium pyrosphate crystal deposition disease, pseudogout and articular chondrocalcinosis. In Arthritis and Allied Conditions. Edited by Koopman W. Baltimore: Williams and Wilkins. 1997, 2013-2025.Google Scholar
  4. Schumacher HR: The synovitis of pseudogout: electron microscopic observations. Arthritis Rheum. 1968, 11: 426-435.PubMedView ArticleGoogle Scholar
  5. Terkeltaub R: Pathogensis of inflammatory manifestations caused by crystals. In Gout, Hyperuricemia and Other Crystal-Associated Arthropathies. Edited by Smyth CJ and Holers VM. Marcel Dekker,. 1999, 1-14.Google Scholar
  6. McCarthy GM, Augustine JA, Baldwin AS, Christopherson PA, Cheung HS, Westfall PR, Scheinman RI: Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein 1, and protein kinase C. J Biol Chem. 1998, 273: 35161-35169. 10.1074/jbc.273.52.35161.PubMedView ArticleGoogle Scholar
  7. Duff GW, Atkins E, Malawista SE: The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians. 1983, 96: 234-245.PubMedGoogle Scholar
  8. Sparrow SA, Hallam LA: Talc granulomas. BMJ. 1991, 303: 58-PubMedPubMed CentralView ArticleGoogle Scholar
  9. Donaldson K: Nonneoplastic lung responses induced in experimental animals by exposure to poorly soluble nonfibrous particles. Inhal Toxicol. 2000, 12: 121-139. 10.1080/089583700196563.PubMedView ArticleGoogle Scholar
  10. Goldner RD, Adams DO: The structure of mononuclear phagocytes differentiating in vivo. III. The effect of particulate foreign substances. Am J Pathol. 1977, 89: 335-350.PubMedPubMed CentralGoogle Scholar
  11. Strouse PJ, Londy F, DiPietro MA, Teo EL, Chrisp CE, Doi K: MRI evaluation of infectious and non-infectious synovitis: preliminary studies in a rabbit model. Pediatr Radiol. 1999, 29: 367-371. 10.1007/s002470050609.PubMedView ArticleGoogle Scholar
  12. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, Yeung YG: Biology and action of colony-stimulating factor-1. Mol Reprod Dev. 1997, 46: 4-10. 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V.PubMedView ArticleGoogle Scholar
  13. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, Chisholm O, Hofstetter W, Pollard JW, Stanley ER: Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 1994, 120: 1357-1372.PubMedGoogle Scholar
  14. Hamilton JA, Myers D, Jessup W, Cochrane F, Byrne R, Whitty G, Moss S: Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol. 1999, 19: 98-105.PubMedView ArticleGoogle Scholar
  15. Hamilton JA, Byrne R, Whitty G: Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1. J Leukoc Biol. 2000, 67: 226-232.PubMedGoogle Scholar
  16. McCarty DJ, Palmer DW, James C: Clearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. Arthritis Rheum. 1979, 22: 1122-1231.PubMedView ArticleGoogle Scholar
  17. Cheung HS, Story MT, McCarty DJ: Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum. 1984, 27: 668-674.PubMedView ArticleGoogle Scholar
  18. Jaworowski A, Wilson NJ, Christy E, Byrne R, Hamilton JA: Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal. J Biol Chem. 1999, 274: 15127-15133. 10.1074/jbc.274.21.15127.PubMedView ArticleGoogle Scholar
  19. di Giovine FS, Malawista SE, Thornton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest. 1991, 87: 1375-1381.PubMedPubMed CentralView ArticleGoogle Scholar
  20. Firestein GS, Xu WD, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, Zvaifler NJ: Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med. 1988, 168: 1573-1586.PubMedView ArticleGoogle Scholar
  21. Abd AH, Savage NW, Halliday WJ, Hume DA: The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Lymphokine Cytokine Res. 1991, 10: 43-50.PubMedGoogle Scholar
  22. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA: The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000, 68: 144-150.PubMedGoogle Scholar
  23. Jutila MA, Banks KL: Increased macrophage division in the synovial fluid of goats infected with caprine arthritis-encephalitis virus. J Infect Dis. 1988, 157: 1193-1202.PubMedView ArticleGoogle Scholar
  24. Yamada M, Naito M, Takahashi K: Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol. 1990, 47: 195-205.PubMedGoogle Scholar

Copyright

© Hamilton et al, licensee BioMed Central Ltd 2001